Britain and it's Biomedical Research Stratergy.

Britain's big push for today (5/12/11) has been to announce it's strategy to encourage Biomedical Research companies such as pharmaceutical companies to invest in the UK. The big announcement was trailed yesterday (4/12/11) with an announcement that these companies would be rewarded with access to confidential NHS patient records otherwise known as medical notes. This announcement performed a number of functions;

Firstly it allowed the Prime Minister to portray himself internationally as the hero of the common man standing up to the Crown which genuinely views the British people not as people but as living commodities to which anything can be done in order to make a profit. He was of course doing this by being seen to provoke a discussion on the topic.

Secondly it allows Britain to enquire how many nations have obtained copies of my grandmother's medical records and performed forensic psychiatric assessments on them. We already know that Norway has and come to a very different conclusion to the British doctors. The Prime Minister of Norway Jens Stoltenburg was today (5/12/11) giving a speech opening the High Level Segment of the COP17/CMP7. Norway of course is still under a lot of pressure over the Anders Breivik case which involves some very complex legal and psychological questions. As psychology is basically the study of human behaviour I don't think it is appropriate for me to discuss it in any further detail at this time.

Thirdly it allows Britain to enquire whether transnational Biomedical research companies think that patents or Intellectual Property Rights (IPR's) granted to Biomedical companies operating in the UK can be assured on the global market. IPR's have always been a controversial topic at COP/CMP summits especially amongst farmers and indigenous peoples groups. So Britain also seems to be trying to excite these observers groups in order to get them to cause trouble as some of them did at the COP15/CMP5.